Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To show non-inferiority in the incidence rates of elevated calcium-phosphorus product between
two treatment groups: 1) a group having an initial dose based on baseline PTH (baseline
iPTH/80) and 2) a group having a starting dose based on body weight (0.04 mcg/kg).